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Abstract
A body mass index (BMI)>22kg/m2 is a risk factor for type 2 diabetes (T2D) in Aboriginal
Australians. To identify loci associated with BMI and T2D we undertook a genome-wide as-
sociation study using 1,075,436 quality-controlled single nucleotide polymorphisms (SNPs)
genotyped (Illumina 2.5M Duo Beadchip) in 402 individuals in extended pedigrees from a
Western Australian Aboriginal community. Imputation using the thousand genomes
(1000G) reference panel extended the analysis to 6,724,284 post quality-control autosomal
SNPs. No associations achieved genome-wide significance, commonly accepted as
P<5x10-8. Nevertheless, genes/pathways in common with other ethnicities were identified
despite the arrival of Aboriginal people in Australia>45,000 years ago. The top hit
(rs10868204 Pgenotyped = 1.50x10
-6; rs11140653 Pimputed_1000G = 2.90x10
-7) for BMI lies 5’
of NTRK2, the type 2 neurotrophic tyrosine kinase receptor for brain-derived neurotrophic
factor (BDNF) that regulates energy balance downstream of melanocortin-4 receptor
(MC4R). PIK3C2G (rs12816270 Pgenotyped = 8.06x10
-6; rs10841048 Pimputed_1000G =
6.28x10-7) was associated with BMI, but not with T2D as reported elsewhere. BMI also as-
sociated with CNTNAP2 (rs6960319 Pgenotyped = 4.65x10
-5; rs13225016 Pimputed_1000G =
6.57x10-5), previously identified as the strongest gene-by-environment interaction for BMI in
African-Americans. The top hit (rs11240074 Pgenotyped = 5.59x10
-6, Pimputed_1000G =
5.73x10-6) for T2D lies 5’ of BCL9 that, along with TCF7L2, promotes beta-catenin’s tran-
scriptional activity in the WNT signaling pathway. Additional hits occurred in genes affecting
pancreatic (KCNJ6, KCNA1) and/or GABA (GABRR1, KCNA1) functions. Notable associa-
tions observed for genes previously identified at genome-wide significance in other popula-
tions includedMC4R (Pgenotyped = 4.49x10
-4) for BMI and IGF2BP2 Pimputed_1000G =
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2.55x10-6) for T2D. Our results may provide novel functional leads in understanding disease
pathogenesis in this Australian Aboriginal population.
Introduction
Genome-wide association studies (GWAS) have been used with great success to identify genes
associated with complex diseases [1], including obesity and type 2 diabetes (T2D) [2–6]. How-
ever, there are no published data on the use of this approach to study complex diseases in Ab-
original Australians. This is partly a reflection of the controversy surrounding genetic research
in indigenous communities [7, 8], which has raised ethical concerns including a lack of benefit
to community and diversion of attention and resources from non-genetic causes of health dis-
parities and racism in health care [9–12]. Controversy relating to the Human Genetic Diversity
Project has acted as a particular barrier to conducting genetic research in Australian Aboriginal
communities [13], but there is now a strong lobby to bring the benefits of health-based geno-
mic research to Australian Aboriginal populations [14] as there is for all ethnicities globally
[8, 15]. T2D and associated pathologies are a major health problem in Indigenous Australians,
and a body mass index (BMI)>22kg/m2 is a significant risk factor for T2D in Australian Ab-
original populations [16]. Here we present the first GWAS of BMI and T2D in a Western Aus-
tralian Aboriginal population.
Materials and Methods
Study population
Subjects for the discovery GWAS were recruited from an Australian Aboriginal community of
Martu ancestry [17, 18] at the edge of the Western Desert inWestern Australia. A family-based
study was proposed to take account of recent population history and shared ancestry. A memo-
randum of understanding (MoU) was established with the community, which included permis-
sion for access to clinical records held in a Communicare database at the local Aboriginal Health
Service. An individual was classified as having T2D if the subject was: (1) diagnosed with T2D
by a qualified physician; (2) on a prescribed drug treatment regimen for T2D; and (3) returned
biochemical test results of a fasting plasma glucose level of at least 7 mmol/l in SI units based on
criteria laid down by theWorld Health Organization (WHO) consultation group report [19].
Multiple height and weight measures per individual were recorded in Communicare through
time and converted within the database to BMI according to the standard formula BMI = weight
(kg)/height (m2). DNA was prepared from saliva samples collected into Oragene tubes (DNA
Genotek, Ontario, Canada) from 405 consenting family members who were available at the time
of visits by the study team during the two-year collection period of the study.
Ethical approvals
Ethical approval for the study was obtained from the Western Australian Aboriginal Health
Ethics Committee (WAAHEC; Reference 227 12/12), who reviewed and approved forms for
informed consent. Each individual (or the parent or guardian of individuals less than 18 years
of age) signed separate informed consent forms to participate in the study and to provide a
DNA sample. Following feedback of results to the community, permission to publish was pro-
vided by the Board of the local Aboriginal Health Service, which comprised elders representing
the extended families residing in the area. Permission to lodge de-indentified genotype and
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basic demographic data (broad geographical location, age, sex and phenotype information) in
the European Genome-phenome Archive (accession number EGAS00001001004) was also ob-
tained from the Board of the local Aboriginal Health Service.
Genotyping, quality control, and analysis of population structure
DNA from the 405 consenting individuals were genotyped on the Illumina Omni2.5 BeadChip
(outsourced to the Centre for Applied Genomics, Toronto, Ontario, Canada). Quality control
(QC) data from the service provider indicated a call rate of (mean [SD]) 99.680% [0.005%].
Further in-house QC procedures at the level of individuals resulted in one individual being
dropped due to a missing data rate>5%, 2 exclusions due to unintentional duplication, and no
exclusions due to outlying heterozygosity (using 3 standard deviation limits), discordant sex,
or divergent ancestry (since mixed models were employed to take account of ancestry, cf.
below). This provided a post-QC dataset of 402 family members, including 361 with repeated
body mass index measurements and 391 (89 cases, 302 family members unaffected at the time
of collection) with information on doctor diagnosed T2D as per criteria outlined above. SNPs
with minor allele frequency (MAF)<0.05, or with more than 5% missing data, were removed
prior to association analysis (cf. below). As family data were employed in our study, complicat-
ed by a degree of over-relatedness in the pedigrees, a check of Hardy Weinberg Equilibrium
(HWE) was not used as a SNP QC check since it was not clear that we should expect all SNPs
to be in HWE. A subset of 70,420 genotyped SNPs with pairwise linkage disequilibrium (LD;
r2)0.3 and MAF>0.01 was used in principal component analysis (PCA; SMARTPCA within
EIGENSOFT [20, 21]) to look at population substructure across the 402 family members.
Imputation procedures
Pre-phasing of genotyped data was performed using SHAPEIT [22], and imputation conducted
using IMPUTE2 [23] with 1000 Genomes (1000G) haplotypes [Phase I integrated variant set
release (v3)]. The reference panel includes haplotypes of 1,092 individuals from Africa, Asia,
Europe and the Americas. For association analysis, probabilistic imputed SNP genotypes were
converted to hard genotype calls provided the posterior probability of the most likely genotype
was>0.9, and imputed SNPs were retained only if they had `info’ score>0.5, MAF>0.01 and
<10% missing data. To assess imputation accuracy, IMPUTE2 provides measures of concor-
dance and squared Pearson correlation (r2) for each genotyped SNP. Directly genotyped SNPs
were masked then imputed and concordance between the true genotype and the most likely
imputed genotype [where probability prediction threshold> 0.9] for each SNP was calculated
[24–26], as well as r2 between the true (discrete) allele dosage (coded as 0, 1 and 2 correspond-
ing to the number of minor alleles) and the imputed (continuous) allelic dosages. For low fre-
quency SNPs, r2 is the preferred accuracy measure because, unlike concordance, allele
frequency is taken into account. We also compared these imputation accuracies for the 195 in-
dividuals determined by PCA to represent pure Martu ancestry against the 207 deemed to be
of mixed ethnicity by PCA, using the data generated from imputation of the full dataset for the
402 individuals.
Heritability and association analyses
Heritability for mean BMI was determined from self-reported pedigree structures using the
QTDT software package [27], and separately on the basis of kinship and IBD sharing from
SNP-chip data calculated using the R package GenABEL v1.7–6 [28] and using the genome-
wide complex trait association (GCTA) tool [29]. To provide a visual display of relatedness
across the 402 genotyped individuals, the genomic kinship matrix was first calculated in
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GenABEL v1.7–6 [28], and then converted to a distance matrix followed by hierarchical cluster
analysis using single linkage on the dissimilarities. The ape package [30] was used to produce a
radial tree plot for the 402 genotyped individuals. For association analyses, the FAmily-based
Score Test for Association (FASTA) [31] in GenABELv1.7–6 [28] was employed that uses a lin-
ear mixed model (LMM) approximation to model the trait outcome, with whole genome data
used to estimate kinship (in order to account for relatedness) and to take account of population
substructure. Analyses were carried out using quantitative trait data (BMI), and separately to
compare all T2D cases with all unaffected individuals. Association results for genotyped data
obtained using GenABEL were compared with results using FaST-LMM [32]. Both GenABEL
(FASTA) and FaST-LMMmodel disease status (control/case for T2D, coded 0/1) as if it were a
normally distributed quantitative variable, which has been shown [33] to produce a valid test
with respect to testing the null hypothesis of no association. Power calculations using
QUANTO [34] show that 361 individuals with BMI measures provide a maximum of 80%
power to detect associations at genome wide significance levels (P<5×10-8), or a maximum of
97% power at suggestive significance levels (P<1×10-5), for SNPs with MAF>0.3 conferring al-
lelic effects (betas) of magnitude half a unit of standard deviation. For effects (betas) of magni-
tude 0.25 units of standard deviation, the maximum powers achievable are lowered to 1% and
9% respectively. The 89 T2D cases and 302 unaffected family members provide a maximum of
32% power to detect associations at genome wide significance levels (P<5×10-8), or 71% power
at suggestive significance levels (P<1×10-5), for SNPs with MAF>0.3 conferring allelic odds
ratios>2.5. For odds ratios of 1.5, the powers are lowered to 1.4% and 0.06% respectively.
Manhattan plots were generated using the mhtplot() function of ‘gap’, a genetic analysis
package for use in R (see URLs). Quantile-quantile (Q-Q) plots were generated, and inflation
factors (denoted λ) calculated in R version 2.15.0 by dividing the median of the observed chi-
squared statistics by the median of the theoretical chi-squared distribution. Regional plots of
association were created using LocusZoom [35] in which—log10 P-values were graphed against
their chromosomal location. Pairwise LD patterns between all regional SNPs and the top SNP
were calculated specifically for this Australian Aboriginal study data using 146 unrelated indi-
viduals from the total sample of 402 genotyped individuals. The 146 unrelated individuals were
selected by iterative removal of the individuals with the greatest number of estimated relation-
ships with IBD>0.1875.
Bioinformatic analysis
Global alignment of genomic sequence for the region SLC28A3 to NTRK2 from human, cow
and mouse was undertaken to locate evolutionarily conserved non-coding sequences (CNS) that
might contain regulatory elements and transcription factor binding sites (TFBS). Genomic se-
quences for the three organisms were exported in FASTA format from ENSEMBL (Genome
Reference Consortium Release 37, Ensembl Release 67) and associated annotation exported in
the form of a General Feature File (GFF) file. The global alignment tool Multi-LAGAN [36, 37]
was used to align genomic sequences using the guide tree (((human) cow) mouse). SYNPLOT
[38] was used to visualize the annotated alignment. CNS, defined here as regions with a nucleo-
tide sequence conservation level of0.7 (i.e. to the least conserved exon sequence in the
genes flanking the region of interest), were analysed for promoter and enhancer elements using
PROMO [39], AliBaba v2.1 [40], and MatInspector v8.0.5 [41] with a matrix similarity parame-
ter>0.75. We also used the UCSC genome-browser (see URLs) with custom tracks to assess
where selected top-hit SNPs are located in relation to elements such as CpG islands or repeat el-
ements (LINES; SINES). To look de novo for CpG island-like elements, we firstly masked repeat
regions using RepeatMasker (see URLs) following which putative CpG islands were searched
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for using CpGIsland Searcher [42] with parameters set at 50%GC, 0.60 observed CpG/expected
CpG ratio, and length 200bp (rather than the default settings of 55%, 0.65, and 500bp).
Results
Characteristics of the study population
The 402 post-QC genotyped individuals used in the GWAS belonged to a small number of
inter-related extended pedigrees, as depicted in the radial plot which shows hierarchical clus-
tering of estimated pairwise identity-by-descent allele-sharing (S1 Fig.). Principal component
analysis (S2 Fig.) demonstrated a degree of introgression of predominantly Caucasian origin,
with a tight cluster of 195 individuals of Martu Aboriginal ancestry across all age groups. Linear
mixed models were used in the genetic analysis to take account of both family relationships
and this genetic substructure. S1 Table provides basic demographic data (age, sex; at the time
of diagnosis and/or collection) for the 391 individuals used in the genetic analyses. De-identi-
fied BMI data was also available for 1020 self-reporting Aboriginal individuals in the popula-
tion-specific Communicare database.
BMI in the study population
A BMI>22kg/m2 is a significant risk factor for T2D in Australian Aboriginal populations [16].
Fig. 1 part A provides a plot of all BMI measurements for self-reported Aboriginal individuals
in the study population (N = 1020). BMI by age was plotted using the R package SITAR [43]
for all records in Communicare. Separate lines trace multiple measurements over time per indi-
vidual; females (pink lines) and males (blue lines). The heavy lines show the polynomial quintic
(power of 5) curves for females (pink heavy line) and males (blue heavy line) that best fit the
data. Fitting separate (by gender) curves to the data (Fig. 1 part A) provided a significantly bet-
ter fit (P = 10-9) than fitting a single curve with a sex-specific displacement. We constructed
standardized residuals from these curves by subtracting the observed BMI value from the fitted
curve and dividing by the estimated standard deviation (calculated within 1-year age brackets).
All GWAS analyses of BMI (cf. below) were carried out using these standardized residuals. The
extreme female outlier was not used in fitting the female polynomial curve or in any of the
GWAS analyses. This analysis of BMI shows (a) that the majority of the adult population have
BMI>22 and are therefore at increased risk of diabetes; (b) a proportion of 15–20 year olds
also fall into this category; and (c) there are many individuals in the community who can be
classified as overweight (BMI 25.00–29.99) or obese (including class I obesity BMI
30.00–34.99; severe or class II obesity BMI 35–39.99; and morbid or class III obesity BMI40)
according to Center for Disease Control (CDC) [44] and World Health Organization (WHO)
[45] international criteria. By estimating familial correlations based on self-reported pedigree
structures using QTDT [27], we estimated heritability for mean BMI in this population to be
55%, broadly in line with other populations internationally [46–48]. Estimation of heritability
on the basis of kinship and IBD sharing from the SNP-chip data using the R package GenABEL
[28] gave a lower estimate of 38%, consistent with the estimate of 39% (95% confidence interval
[17%-61%]) provided by GCTA [29].
T2D in the study population
Our dataset for the study population (Fig. 1 part B) showed that>75% of adults (20 years of
age) fall above the BMI cut-off of>22 for increased risk of T2D in Aboriginal Australians [16].
Fig. 1 part B also highlights BMI curves for individuals in the study sample with T2D (heavy
pink lines for females; heavy blue lines for males). This demonstrates that our study population
First GWAS in an Australian Aboriginal Population
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Fig 1. BMI by age plotted using the R package SITAR. (A) plot of all records for self—reporting Aboriginals
(N = 1020) in the Aboriginal Health Service’s Communicare database; and (B) plot of all records for the 391
genotyped individuals contributing to association analyses for BMI and T2D. Separate lines trace multiple
measurements over time per individual; females (pink) and males (blue). The heavy lines in (A) show the
polynomial quintic (power of 5) curves for females (pink heavy line) and males (blue heavy line) that best fit
First GWAS in an Australian Aboriginal Population
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is characterized by T2D predominantly associated with high risk BMI measurements, including
a number of cases<20 years of age. S2 Fig. part D highlights on a PCA plot the individuals
with T2D used in the GWAS. Of the 391 individuals used in the T2D GWAS (cf. below), there
were 65 with T2D from 191 individuals (34%) that fell within the pure Martu ancestry cluster
(S2 Fig. parts E and G), and 24 with T2D from 200 individuals (12%) of mixed ethnicity. There
was insufficient power to analyse GWAS data separately for T2D associated with low to normal
(<25; N = 10) BMI or with low (<20 years of age; N = 5) age at onset. There will be some loss
of power in the analysis with the inclusion of unaffected individuals less than 20 years of age
(since ~10–20% of them may go on to get T2D[16]). This had to be balanced against the gain
in power with the increased sample size and greater contribution of individuals in controlling
for population substructure and relatedness in the analysis. S1 Table shows the age range and
BMI for unaffected individuals<20 and>20 years of age separately. Importantly, there will be
no false positive associations generated by including all unaffected individuals in the GWAS
analysis for T2D (cf. below).
GWAS analyses for BMI based on genotyped SNPs
Longitudinal BMI data available for the 361 post-QC individuals with both BMI measurements
and genotyped SNP-chip data were representative of the full range of BMI values in the popula-
tion (Fig. 1 part B). To identify loci associated with BMI we undertook a GWAS using
1,075,436 post quality control genotyped SNPs in these 361 individuals. For longitudinal BMI
data (designated BMI-longitudinal), the analyses in GenABEL and FaST-LMM used each indi-
vidual BMI reading as a separate observation, using the standardized residual from the fitted
curve as the trait of interest and modelling the correlation between readings via the estimated
kinship. This does not fully account for the correlation between readings as readings from the
same person are likely to be more correlated, especially since they are often measured at fre-
quent (close together) time points. The Genomic Control deflation factor [49] was therefore
employed in GenABEL to avoid inflation of the overall distribution of test statistics; this correc-
tion was not found to be necessary in FaST-LMM, as previously noted [50]. Association analy-
ses were also undertaken in GenABEL and FaST-LMM using the mean of all BMI readings for
an individual (designated BMI-mean) as the trait. Although this raises issues of differential var-
iation in BMI-mean due to uneven numbers of readings between individuals, results from
these two different analyses were well correlated. The plots presented at S3 Fig. demonstrate
that association results for BMI-mean and BMI-longitudinal obtained using FASTA in GenA-
BEL (S3 Fig. part A) or using FaST-LMM (S3 Fig. part B) were highly correlated. Therefore de-
tailed results are given only for BMI-longitudinal (hereinafter referred to as BMI). Similarly,
results obtained for each phenotype from GenABEL and FaST-LMM were strongly concordant
(S4 Fig.), consistent with our recent evaluation of a range of software implementations for line-
ar mixed models [50]. Q-Q plots (S5 Fig.) for GenABEL (λ BMI-longitudinal = 1.0; λ BMI-
mean = 1.02) and FaST-LMM (λ BMI-longitudinal = 1.00; λ BMI-mean = 1.00) analyses also
showed equivalent inflation factors. Therefore detailed results presented hereafter are given
only for analyses undertaken using FASTA in GenABEL.
A Manhattan plot showing the genome-wide results for BMI based on the genotyped data is
presented in Fig. 2 part A. The top hits did not achieve genome-wide significance, commonly
accepted as P<5×10-8 [51] and concordant with the number of post-QC SNPs (P = 0.05/
the data. Fitting separate (by gender) curves to the data provided a significantly better fit (P = 10-9) than fitting
a single curve. The extreme outlier was not used in fitting the female polynomial curve. In (B), individuals with
T2D are shown in heavy lines.
doi:10.1371/journal.pone.0119333.g001
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1,075,436 or 4.65×10-8) used for this analysis of genotyped data. No specific SNPs reported to
achieve genome-wide significance for association with BMI in other populations achieved
P<10-2 in our study, as determined by interrogation of the NIH NHGRI Catalogue of GWAS
studies [52]. Nevertheless, since we cannot assume similar patterns of linkage disequilibrium or
directionality of associations in our Australian Aboriginal population, we have provided infor-
mation in S2 Table on SNPs with P<10-2 in our study population for the genes previously re-
ported to achieve genome-wide significance (i.e. P<5×10-8) for association with BMI in other
populations. Notably (cf. below),MC4R (top SNP rs129959775; Pgenotyped = 4.49×10
-4) was pres-
ent in this list. Extending the table to include genes previously reported in GWAS for BMI at
P<10-5 in other populations provided evidence for association at CNTNAP2 (top SNP
rs6960319; Pgenotyped = 4.65×10
-5). SNPs at CNTNAP2 were also among the top 50 SNPs from
the BMI analysis in our study population (S3 Table). Data for CNTNAP2 and other top SNPs in
genes of potential functional relevance, i.e. in pathways previously identified to be associated
with metabolic diseases, are shown in Table 1. Effect sizes (betas 0.35 to 0.72) for these associa-
tions are concordant with our power to detect allelic effects of magnitude half a unit of standard
deviation of the trait. The top hit (rs10868204; Pgenotyped = 2.73×10
-6) for BMI in our study pop-
ulation lies in the intergenic region (Fig. 3; cf. below) 5’ ofNTRK2 encoding the type 2 neuro-
trophic tyrosine kinase receptor for brain-derived neurotrophic factor (BDNF) that regulates
energy balance downstream of melanocortin-4 receptor (MC4R). Both BDNF andMC4R have
previously been shown to be associated with obesity in other populations (see S2 Table). Other
top hits in our population that are of functional interest (Table 1) occurred in RBM7 (rs6848632
Pgenotyped = 1.43×10
-5) which has been related to pancreatic function [53], and at PIK3C2G
(rs12816270 Pgenotyped = 8.06×10
-6) which has previously been associated with T2D [54].
GWAS analyses for T2D based on genotyped SNPs
AManhattan plot showing the GWAS results for T2D for genotyped SNPs is presented in S6 Fig.
part A. Again, the top hits based on analysis of genotyped SNPs did not achieve genome-wide sig-
nificance for T2D, which was less well-powered than the BMI analysis. In addition, no specific
SNPs reported to achieve genome-wide significance for association with T2D in other populations
achieved P<10-2 in our study, as determined by interrogation of the NIHNHGRI Catalogue of
GWAS studies [52]. Nevertheless, as for BMI we cannot assume similar patterns of linkage dis-
equilibrium or directionality of associations in our Australian Aboriginal population. Therefore,
we have provided information in S4 Table for genotyped SNPs with P<10-2 in our study popula-
tion for the genes previously reported to achieve genome-wide significance (i.e. P<5×10-8) for as-
sociation with T2D in other populations. Five genes (ANK1, TSPAN8, PROX1,GLIS3 and
UBE2E2) had genotyped SNPs with P<10-3. Of note, no SNPs at P<10-2 were observed for
TCF7L2 [55–59] or KCNJ11 [60], genes that have previously been associated with T2D across
multiple ethnicities. However, 4 genes (Table 2) represented in the top 50 SNPs (S5 Table) are
supported by strong biological candidacy in related gene pathways. The top hit (rs11240074 Pgeno-
typed = 5.59×10
-6) for T2D in our study population lies 5’ of BCL9 encoding a protein that, along
with TCF7L2, promotes beta-catenin’s transcriptional activity in theWNT signaling pathway. Ad-
ditional hits (1.07×10-4 Pgenotyped4.55×10-5) of functional interest occurred in genes involved
in pancreatic (KCNJ6 [61], KCNA1 [62]) and/or GABA (GABRR1 [63],KCNA1 [64]) functions.
GWAS analyses based on imputed SNP data
Recent reports have focused on improving tools for imputation of SNPs based on both the
1000 genomes (1000G) and HapMap project data [23, 65]. It was of particular interest to deter-
mine how well 1000G imputation would work for this Australian Aboriginal population, given
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that most estimates suggest the arrival of Aboriginal people in Australia more than 45,000
years ago [66, 67]. We therefore examined the efficiency of imputing genotypes across the ge-
nomes of our study population using 1000G data. High average concordance (92.8%-97.9%)
was observed across all chromosomes independently of MAF. Fig. 4 compares the efficiency of
imputation across all chromosomes, as measured by imputation r2, for SNPs at different MAF.
As expected, r2 is lower for SNPs with MAF 0.01–0.03 (mean r2 77.2–85.4) compared to SNPs
with MAF 0.03–0.05 (mean r2 81.5–88.5%) and MAF 0.05–0.5 (mean r2 85.9–90.7%). When
examined across individuals, mean imputation accuracy for the 195 individuals of pure Martu
ancestry (concordance 94.8; r2 88.8) were not different to measures for the 207 individuals of
mixed ethnicity (concordance 95.6; r2 90.0) or to measures across all 402 individuals (concor-
dance 95.2; r2 89.5).
Fig 2. Manhattan plots of genome-wide association results for BMI undertaken using FASTA in GenABEL. (A) results for genotyped data; and (B)
results for 1000G imputed data. SNPs in red show the region of the top association in this discovery GWAS.
doi:10.1371/journal.pone.0119333.g002
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In relation to the GWAS analyses for BMI (Fig. 2 part B; Fig. 3 part B; Table 1; S6 Table),
1000G imputation improved significance for associations at NTRK2 (Fig. 3 part B; Table 1: Pge-
notyped = 1.50×10
-6; Pimputed_1000G = 2.90×10
-7) and at PIK3C2G (Table 1: Pgenotyped = 8.06×10
-
6; Pimputed_1000G = 6.28×10
-7) but not at other genes of functional interest (Table 1). Similarly,
for the T2D imputed GWAS analysis (S6 Fig. part B; S7 Table), top SNPs for 1000G imputed
data in genes of functional interest (Table 2) were generally of the same order of magnitude as
top genotyped SNPs, including support for the top hit at BCL9. Novel findings in the top 100
SNPs for 1000G imputed data included a hit at the previously identified gene for T2D IGF2BP2
(S4 Table: rs138306797, Pimputed_1000G = 2.55×10
-6) that had not achieved P<10-2 in the geno-
typed data, and hits at Pimputed_1000G<10
-6 in genes not previously associated genetically or
functionally with T2D (S7 Table: SATB2/TYW5 on chromosome 2,MTHFD1L/AKAP12 on
chromosome 6; KLF5/KLF12 on chromosome 13).
Genes for obesity or for T2D?
Analysis of T2D and the standardized BMI residual (BMI-longitudinal) was initially performed
without any covariate adjustment. Since T2D and BMI are highly correlated and have been
shown to have shared genetic influences [68], the question arises as to which phenotype is pri-
marily regulated by the genes of interest identified in this study. We therefore repeated the
analyses allowing for BMI and T2D as covariates (S1 Text). Results demonstrated that (A)—
log10P-values for T2D adjusted for the standardized BMI residual were highly correlated with
the original unadjusted analysis for both genotyped and imputed data, and (B) conversely,—
log10P-values for unadjusted BMI and BMI adjusted for T2D were likewise highly correlated.
This suggests that genetic effects on T2D as originally calculated are largely independent of any
effects attributable to the mean standardized BMI residual. Specifically, the significance levels
for genes of functional interest are of the same order of magnitude in both the adjusted
(S1 Text) and the original analysis (Table 2). Similarly, genetic effects on BMI as originally cal-
culated are largely independent of any effects attributable to T2D, consistent with the regional
Table 1. Top GWAS SNP hits in genes of functional relevance for BMI, organized by chromosome.
BMI Genotyped BMI Imputed 1000G
Chromosome SNP NCBI37 A1 A2 effB se_effB Pdeflated effB se_effB Pdeflated SNP Location HGNC*
4 rs6848632 40509521 A C 0.52 0.08 1.43E-05 INTRONIC RBM47
rs6848632 40509521 A C 0.51 0.08 2.50E-05 INTRONIC RBM47
7 rs6960319 147258631 G A -0.36 0.06 4.65E-05 INTRONIC CNTNAP2
rs13225016 147256110 G A -0.35 0.06 6.57E-05 INTRONIC CNTNAP2
9 rs1347857 87173097 A C 0.44 0.06 1.50E-06 INTERGENIC SLC28A3/NTRK2
rs11140653 87152509 C T 0.48 0.06 2.90E-07 INTERGENIC SLC28A3/NTRK2
12 rs12816270 18770577 A G 0.72 0.11 8.06E-06 INTRONIC PIK3C2G
rs10841048 18779259 T C 0.71 0.10 6.28E-07 INTRONIC PIK3C2G
Results are for GWAS analysis in GenABEL using each individual BMI reading as a separate observation, modelling the correlation between readings via
the estimated kinship and using the Genomic Control deflation factor to avoid inflation of the overall distribution of test statistics. Results are for allele-wise
tests under an additive model of inheritance for genotyped SNPs and for imputed data. Bold indicates the top hit for BMI based on both genotyped and
1000G imputed data. Full lists of the top 50 hits for genotyped SNPs, and the top 100 SNPs for imputed data, appear in S3 Table and S6
Table, respectively.
* Genes separated by forward slash indicate nearest protein coding genes upstream/downstream of the SNP. NCBI37 = bp location on chromosome for
NCBI Build 37. A1 = major allele; A2 = minor allele.
doi:10.1371/journal.pone.0119333.t001
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Fig 3. Regional association plots (LocusZoom [35]) of the signal for BMI association in the region
SLC28A3 toNTRK2 on chromosome 9. (A) is the plot for genotyped data; and (B) is the plot for 1000G
imputed data. The −log10 P-values are shown on the upper part of each plot. SNPs are colored (see key)
based on their r2 with the labeled hit SNP (purple), calculated in the 146 unrelated genotyped individuals. The
bottom section of each plot shows the genes marked as horizontal lines. The second Y axis is for
recombination rate, as shown in blue on the plot.
doi:10.1371/journal.pone.0119333.g003
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Table 2. Top GWAS SNP hits in genes of functional interest for T2D, organized by chromosome.
Genotyped Imputed 1000G
Chromosome SNP NCBI37 A1 A2 effB se_effB chi2.1df P1df effB se_effB chi2.1df P1df SNP
Location
HGNC*
1 rs11240074 146996480 A C 0.21 0.05 20.62 5.59E-
06
INTERGENIC CHD1L/
BCL9
rs11240074 146996480 A C 0.21 0.05 20.58 5.73E-
06
INTERGENIC CHD1L/
BCL9
6 rs6930407 89905239 A G 0.13 0.03 16.63 4.55E-
05
INTRONIC GABRR1
rs9451177 89905172 A G 0.13 0.03 17.37 3.08E-
05
INTRONIC GABRR1
12 rs11063387 4998536 G C 0.14 0.03 15.50 8.24E-
05
INTERGENIC KCNA6/
KCNA1
rs11063385 4997051 C T 0.13 0.03 14.97 1.09E-
04
INTERGENIC KCNA6/
KCNA1
21 rs8128418 39188732 G A 0.25 0.06 15.01 1.07E-
04
INTRONIC KCNJ6
rs113713721 39185153 G A 0.26 0.06 15.99 6.38E-
05
INTRONIC KCNJ6
Data analyzed in GenABEL using genotyped or 1000G imputed data for all individuals with doctor-diagnosed T2D. Results are for allele-wise tests under
an additive model of inheritance. Bold indicates top hit for T2D based on both genotyped and imputed data. Full lists of the top 50 hits for genotyped
SNPs, and the top 100 SNPs for imputed data, appear in S5 Table and S7 Table, respectively.
* Genes separated by forward slash indicate nearest protein coding genes upstream/downstream of the SNP. NCBI37 = bp location on chromosome for
NCBI Build 37. A1 = major allele; A2 = minor allele.
doi:10.1371/journal.pone.0119333.t002
Fig 4. Imputation accuracy for 402 genotyped individuals imputed against the 1000G reference panel. Imputation accuracy is measured as average r2
across all autosomes for SNPs of different MAFs (see key).
doi:10.1371/journal.pone.0119333.g004
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association plots (Fig. 3, S7 Fig.) where no evidence for association is seen in plots comparing
T2D results across regions that contained the top hits for BMI. This includes the regions con-
taining RMB7, which previously has been related to pancreatic function [53], and PIK3C2G
which has been associated with T2D in another population [54].
Interrogating the SLC28A3 to NTRK2 intergenic region
As with most GWAS for common complex diseases [69], top SNP hits identified here were
generally located within introns or in potential regulatory regions upstream or downstream of
the gene of interest. In the case of the top hit for BMI (Fig. 3), the peak of association was clear-
ly located upstream of the best functional candidate for BMI, the NTRK2 gene, with little evi-
dence for linkage disequilibrium between SNPs in this peak of association and SNPs within the
coding region of the gene. Conditioning on the top genotyped and top imputed SNPs (S8 Fig.)
reduced all other SNP signals to P>10-3, suggesting a single major signal regulating BMI across
this region. We therefore interrogated the region of top hits upstream of NTRK2 to see if we
could find evidence for potential regulatory elements. Initially we used SYNPLOT to plot the
location of the top genotyped SNPs (P<5×10-6) in relation to CNS upstream of NTRK2
(Fig. 5). These 8 genotyped SNPs were all in strong LD with the top SNP (r2>0.8; Fig. 3). SNP
rs1866439 (Pgenotyped = 1.59×10
-6) was of equivalent significance to the top SNP rs1347857
(Pgenotyped = 1.5×10
-6) and was unique in being the only top SNP located within a CNS peak,
with the risk allele causing loss of a NHP1 binding site falling within a half-palindromic estro-
gen response element (TGAGTagtTGA/GCC) [70, 71]. NTRK2 expression has been shown to
be regulated by estradiol [72]. Other indications that this might be a regulatory region, as anno-
tated on Fig. 5, included: (i) the presence adjacent to rs1866439 of a CpG-island (50%GC; ob-
served CpG/expected CpG 61%; 212bp in length); (ii) a number of peaks of mono-methylation
of lysine 4 of histone H3 (H3K4Me1; frequently found near regulatory regions) as measured by
the ENCODE project (see URLs), including around rs1866439; and (iii) the peak of association
with the top imputed SNPs (Fig. 3 part B) falling within a non-conserved region (no CNSs) of
fragments of long (LINE-1 or L1) interspersed elements or retrotransposons (Fig. 5 and
S9 Fig.). S9 Fig. shows the positions of these top SNPs in relation to the L1 elements, with the
top imputed SNP (rs11140653) specifically falling within a L1MA3 element (as also annotated
on Fig. 5). While full-length L1s are required for retrotransposition [73], regulatory elements
that overlap with fragments of L1 sequence have been shown to be involved in gene silencing
[74]. Further functional studies will be required to determine which variants and elements are
important in regulating NTRK2 in this Aboriginal population.
Discussion
Results of the discovery GWAS undertaken here provide the first hypothesis-free insights into
genetic risk factors for high BMI and T2D in an Australian Aboriginal population. Although
estimates suggest the arrival of Aboriginal people in Australia more than 45,000 years ago
[66, 67], we found that we were able to (A) genotype with high accuracy using the Illumina
2.5M Duo SNP chip, and (B) impute genotypes with high accuracy based on the reference
panel from the 1000 Genomes project [75]. This included imputation accuracy in both the sub-
set of 195 individuals determined by PCA to be of pure Martu ancestry and in the 207 individu-
als in whom we observed varying degrees of introgression with Caucasian genomes. This
imputation accuracy compares favorably with that reported for imputation based on the
1000G reference panel of African and American ancestry groups genotyped on the Illumina
Omni2.5M Duo chips [76]. The major limitation in the present study was sample size and
power, but as a pioneering study in the area of application of modern genomics to Aboriginal
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Fig 5. SYNPLOT [38] for a section of the intergenic region (NCBI Build 37: 87,140,000bp to 87,190,000bp) ~94kb upstream of NTRK2 on
chromosome 9q21.33. Since regulatory elements are usually found with conserved regions of the genome, we interrogated the region of our top hits using
this in silico analysis to look for conserved regions across multiple species. The multiple alignments of (top to bottom) human, cow and mouse sequences
were performed across the complete intergenic region SLC28A3 to NTRK2 using LAGAN. The segment of the alignments shown here is the region that
contains the top association hits (P<5×10-6). The central plotted curves show the degree of conservation of sequence across all three species, on a vertical
First GWAS in an Australian Aboriginal Population
PLOS ONE | DOI:10.1371/journal.pone.0119333 March 11, 2015 14 / 25
health in Australia it is important that results of this study are reported in order to allay con-
cerns about genetic research as applied to health outcomes, to boost confidence in the ap-
proach, and stimulate replication studies in other Australian Aboriginal populations. The
important practical implication of our demonstration that 1000G imputation could be em-
ployed with accuracy in this Australian Aboriginal population is that further cost-effective ge-
nome-wide approaches can be applied to understanding pathogenesis of complex diseases in
Australian Aboriginal populations.
In our study, modest support (P<10-2) was obtained for a number of genes previously
shown to achieve genome wide significance in other populations (see Tables S2 and S4), but
these were generally not represented amongst the top hits observed for our study population.
Of note, no SNPs at P<10-2 were observed for TCF7L2 [55–59] or KCNJ11 [60], genes that
have previously been associated with T2D across multiple ethnicities (though not with Pima
Indians for TCF7L2 [77]). Recent large-scale trans-ancestry meta-analysis shows a significant
excess in directional consistency of T2D risk alleles across ancestry groups [78]. Whilst the
power of our study may have limited our ability to replicate top hits found in large scale popu-
lation-based case-control GWAS and meta-analyses for BMI and T2D, there is increasing sup-
port [79, 80] for the possibility that functional variants that are rare in the general population
may be enriched through highly shared ancestry, identity-by-descent, and linkage in the kind
of extended pedigrees that we have used in our discovery GWAS. Accordingly, our findings
here, while requiring further definitive replication in additional Australian Aboriginal popula-
tions, highlight interesting novel association signals for BMI and T2D that might provide im-
portant clues to disease pathogenesis in this population.
For T2D, the top association in our study population, supported by both genotyped and im-
puted data, was in the region of BCL9. BCL9 encodes a protein that, along with TCF7L2, pro-
motes beta-catenin’s transcriptional activity in the WNT-signaling pathway [81]. WNT-
signaling is important in the transcription of proglucagon, which serves as precursor for the
incretin hormone glucagon-like peptide 1 that stimulates insulin secretion [82]. Additional hits
of functional interest occurred in KCNJ6, KCNA1, and GABRR1. KCNJ6 lies adjacent to
KCNJ15 on chromosome 21q22.13. KCNJ6 is an ATP-sensitive potassium channel that regu-
lates insulin secretion in pancreatic beta cells in response to nutrients [61]. KCNJ15 is another
member of this family of inwardly-rectifying ATP-sensitive potassium channels that has been
shown to be associated with T2D in an Asian population [83]. KCNA1 is the voltage-gated po-
tassium channel Kv1.1 that is expressed in pancreatic β-cells and can influence glucose-stimu-
lated insulin release [62]. It has also been associated with ataxia and epilepsy in humans
carrying rare variants [84], and mutant mice provide a model for ataxia in which Kv1.1 influ-
ences gamma-aminobutyric acid (GABA) release in Purkinje cells of the brain [64]. GABRR1 is
a member of the rho subunit family of GABA A receptors. Previous studies in China have dem-
onstrated association between polymorphisms at GABRR1 and diabetic cataract [63]. Recently
we also demonstrated that polymorphisms in both GABA-A and GABA-B receptor pathway
genes are associated with T2D in an extended family from the United Arab Emirates [85].
GABA-A receptors act as inhibitory neurotransmitters in the central nervous system. They are
scale 0–1 (= 100%), such that the peaks represent CNS. CNS are defined here as regions with a nucleotide sequence conservation level of0.7, i.e. to the
least conserved exon sequence in the two genes (not shown on this plot) SLC28A3 andNTRK2 flanking the intergenic region of interest. Blue boxes indicate
repetitive sequence in all 3 species. The human sequence is also annotated with positions of: (i) LINE-1 elements (yellow); (ii) the top genotyped SNPs (red
vertical bars) including the top SNP rs1086204, and the SNP of interest rs1866439; (iii) the top imputed SNPs (blue vertical bars) including the top SNP
rs1140653; (iv) the CpG island-like element identified using CpG Island Seacher (green); and (v) positions of peaks of mono-methylation of lysine 4 of
histone H3 (H3K4Me1) as measured in NHEK or NHLF cell lines (mauve) or in H1-hESC human embryonic stem cells (orange) by the ENCODE project, as
identified using the UCSC browser (see S9 Fig.).
doi:10.1371/journal.pone.0119333.g005
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also present in the endocrine part of the pancreas at concentrations comparable to those in the
central nervous system, and co-localize with insulin in pancreatic beta cells [86]. Recent work
has shown a role for both GABA-A and GABA-B receptors in regulating insulin secretion and
glucagon release in pancreatic islet cells from normo-glycaemic and T2D individuals [87].
Amongst our top hits for BMI was PIK3C2G, a gene previously associated with T2D and
with serum insulin levels in Japan [54]. PIK3C2G is a member of a conserved family of intra-
cellular phosphoinositide 3-kinases known to be involved in a large array of cellular functions.
Daimon and coworkers [54] related their association to prior observations [88] of expression
of PIK3C2G in the pancreas. However, recent GWAS have observed associations between poly-
morphisms at PIK3C2G and hyperlipidemia and myocardial infarction [89].
A second hit for BMI in our population was CNTNAP2 that encodes contactin associated
protein-like 2 which localizes to the juxtaparanodal region of the nodes of Ranvier in myelinat-
ed axons, where it is required for proper localization of the potassium voltage-gated channel
KCNA1 [90]. Mutations in Cntnap2 in mice impair Kv1.1 localization, and can be obesity-
promoting or obesity-resistant in diet-induced obesity depending on genetic background [91].
Polymorphism at CNTNAP2 was among the strongest gene x environment interactions among
African-Americans with BMI as outcome, specifically interacting with dietary energy intake
[92]. CNTNAP2 is amongst genes that lie within regions of de novo duplications and deletions
recently linked to syndromic obesity in children [93].
Perhaps the most convincing association observed in our study was between BMI and SNPs
that lie in the intergenic region between SLC28A3 and NTRK2 on chromosome 9q21.33.
SLC28A3 is a concentrative nucleoside transporter with broad specificity for pyrimidine and
purine nucleosides [94], and is therefore not a strong candidate genetic risk factor for BMI. On
the other hand, NTRK2 (also known as TRKB or tyrosine kinase receptor B) is the receptor for
BDNF and regulates energy balance downstream of MC4R. Associations between BMI and
SNPs at bothMC4R [95–97] and BDNF [98, 99] have achieved genome-wide significance in
multiple independent studies, but association between NTRK2 and BMI has only previously
been observed (P = 1.04×10-6) in a gene-centric multi-ethnic meta-analysis of 108,912 individ-
uals genotyped on the ITMAT-Broad-Candidate Gene Association Resource (CARe) array
containing 49,320 SNPs across 2100 metabolic and cardiovascular-related loci [100]. Mouse
Bdnfmutants that express decreased amounts of Ntrk2 show hyperphagia and maturity-onset
obesity [101], while risk variants in human BDNF were significantly associated with more food
servings in a study of obesity susceptibility loci and dietary intake [102]. Deficiency in MC4R
signaling reduces expression of BDNF in ventromedial hypothalamic nuclei, indicating that
BDNF and its receptor NTRK2 are downstream components in the MC4R-mediated control of
energy balance. Overall, our data are consistent with meta-analysis [96] of large-scale GWAS
of BMI that, along with data from rare monogenic forms of obesity [103], highlight a neuronal
influence on body weight regulation.
In summary—we report here data for the first GWAS of complex disease in an Australian
Aboriginal population. Whilst the top hits for BMI and T2D are in novel genes not yet reported
for other GWAS, they occur in genes that belong to key pathways strongly supported by previ-
ous GWAS in other ethnicities. This means that current international efforts [82, 104, 105] to
target these pathways will be relevant and translatable to the Australian Aboriginal population,
and the genes identified here may indeed provide novel targets in this endeavour.
Online Resources
The URLs for web resources presented herein are as follows:
R version 2.15.0, http://www.R-project.org/
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The mhtplot() function of ‘gap’ for R, http://www.mrc-epid.cam.ac.uk/Personal/jinghua.
zhao/r-progs.htm
UCSC genome-browser, http://ucscbrowser.genenetwork.org/cgi-bin/hgGateway
The Encode Project, http://www.genome.gov/encode/
Smit AFA, Hubley R, Green P (1996–2010) RepeatMasker Open-3.0. http://www.
repeatmasker.org
Supporting Information
S1 Fig. Radial plot showing hierarchical clustering of estimated pairwise identity-
by-descent allele-sharing for the 402 genotyped individuals used in this study. The genomic
kinship matrix was first calculated in GenABEL v1.7–6, and converted to a distance matrix and
hierarchical cluster analysis using single linkage on the dissimilarities. The ape package was
used to produce radial tree plot.
(PDF)
S2 Fig. Principal component (PC) analysis (PCA) plots showing population substructure
in the study population. A subset of 70,420 genotyped SNPs with pairwise linkage disequilibri-
um (LD; r2)0.3 and MAF>0.01 was used in PCA (SMARTPCA within EIGENSOFT) to
look at population substructure across the 402 genotyped family members. Plots (A) PC1 x
PC2, (B) PC1xPC3, and (C) PC2xPC3 show individuals, color coded by age (see key). (D)
shows the PC1 x PC2 plot in which individuals are color coded (see key) according to their T2D
status. PCA plots (E) PC1 x PC2, (F) PC1xPC3, and (G) PC2xPC3 show individuals color
coded by ancestry (see key). Note that the Martu clusters comprise 73 individuals aged< 20, 25
individuals aged 20–30, 57 individuals aged 30–50, and 40 individuals aged> 50. Hence there
is no evidence for disproportionate representation in any age class. Reference HapMap popula-
tions are not included at the specific request of the Board of the Aboriginal Health Service.
(PDF)
S3 Fig. Demonstrates the strongly correlated GWAS results (genotyped data) for mean
BMI compared with BMI longitudinal for (A) FASTA GenABEL, and (B) Fast-LMM analy-
ses.
(PDF)
S4 Fig. Demonstrates the strongly correlated GWAS results (genotyped data) for FASTA
GenABEL versus Fast-LMM for (A) mean BMI, and (B) BMI longitudinal.
(PDF)
S5 Fig. Provides Q-Q plots and associated lambda values for GWAS analyses undertaken
for (A) FASTA GenABEL BMI longitudinal, (B) FASTA GenABEL mean BMI, (C) Fast-
LMM BMI longitudinal, (D) Fast-LMMmean BMI.
(PDF)
S6 Fig. Manhattan plots of genome-wide association results for T2D undertaken using
FASTA in GenABEL. (A) results for genotyped data; and (B) results for 1000G imputed data.
SNPs in red show the region of the top association in this discovery GWAS.
(PDF)
S7 Fig. Regional association plots (Locuszoom) of the imputed SNP signals for BMI (upper
graph) and T2D (lower graph) in specific regions. (A) SLC28A3 to NTRK2 on Chromosome
9; (B) CNTNAP2 on Chromosome 7; (C) RBM7 on Chromosome 4; and (D) PIK3C2G on
Chromosome 12. In each plot the −log10 P-values are shown on the upper section, with SNPs
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colored (see key) based on their r2 with the labeled top hit SNP (purple), calculated in the 146
unrelated genotyped individuals. Red arrows highlight the position of the BMI hit on the T2D
plot. The bottom section of each plot shows the genes marked as horizontal lines.
(PDF)
S8 Fig. Regional association plots (Locuszoom) of the signals for (A) BMI genotyped and
(B) BMI imputed in the region SLC28A3 to NTRK2 on Chromosome 9 before (upper
graph) and after (lower graph) conditioning on the top SNPs rs1347857 and rs11140653,
respectively. Analysis undertaken using an additive model in FaST-LMM.
(PDF)
S9 Fig. Plot generated in the UCSC genome-browser for a section of the intergenic region
(NCBI Build 37: 87,140,000bp to 87,190,000bp) ~94kb upstream of NTRK2 on Chromo-
some 9q21.33. The plot shows positions of the top (P<5×10-6) genotyped (in red vertical
lines) and 1000G imputed (in blue vertical lines) SNPs, with the top imputed SNP (rs1140653),
the top genotyped SNP (rs1347857) and the SNP of functional interest discussed in the main
text (rs1866439) shown again on separate rows. These SNPs are shown relative to: (i) the CpG
island-like motif identified using CpG Island Searcher; (ii) the various fragments of LINE-1
(L1) elements (with the L1MA3 element in which the top imputed SNP is located shown in
blue); and (iii) peaks of histone methylation (H3K4Me1, H3K4Me3) or acetylation (H3K27Ac)
measured in 7 cell lines from the ENCODE project.
(PDF)
S1 Table. Characteristics of the family-based Aboriginal study sample. The 391 post-QC
genotyped individuals used in the GWAS belonged to a small number of interrelated extended
pedigrees, as depicted in the radial plot of pairwise identity-by-descent allele-sharing presented
in S1 Fig.
Characteristics of the 391 genotyped individuals used in the GWAS are provided here.
(PDF)
S2 Table. SNP associations at P<0.01 observed in the WA Aboriginal study population for
genes previously reported to achieve P<5×10-8 (or P<10-5 shaded grey) for association
with BMI in other populations. Bold indicates a SNP hits observed in the imputed but not the
genotyped data, including at DICER (P<10-6).
(PDF)
S3 Table. Top GWAS autosomal SNP hits for BMI, organised by chromosome. Results for
the top 50 hits for “BMI longitudinal” GWAS analysis in GenABEL using each individual BMI
reading as a separate observation, modelling the correlation between readings via the estimated
kinship and using the genomic control deflation factor to avoid inflation of the overall distribu-
tion of test statistics. Results are for allele-wise tests under an additive model of inheritance.
Bold indicates SNP associations of functional interest presented in main Table 1.
(PDF)
S4 Table. SNP associations observed at nominal P<0.01 in the WA Aboriginal study popu-
lation for genes previously reported to achieve P<5×10-8 for association with T2D in other
populations. Bold indicates SNP hits observed in the imputed but not the genotyped data, in-
cluding at IGF2BP2 (P<10-5).
(PDF)
S5 Table. Top 50 GWAS SNP hits for T2D, organised by chromosome. Results are for allele-
wise tests under an additive model of inheritance. Bold indicates SNP associations of functional
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interest presented in main Table 2.
(PDF)
S6 Table. Top GWAS imputed SNP hits for BMI, organised by chromosome. Results for the
top 100 hits for “BMI longitudinal” GWAS analysis in GenABEL using each individual BMI
reading as a separate observation, modelling the correlation between readings via the estimated
kinship and using the genomic control deflation factor to avoid inflation of the overall distribu-
tion of test statistics. Results are for allele-wise tests under an additive model of inheritance.
Bold indicates 3 top SNP associations for imputed data (P<10-6) coincide with two top genes
of functional interest (NTRK2, PIK3C2G) presented in main Table 1, as well as a hit near
DICER a previously observed GWAS hit for BMI (see S2 Table).
(PDF)
S7 Table. Top GWAS imputed SNP hits for T2D, organised by chromosome. Results are for
the top 100 hits for T2D GWAS analysis in GenABEL for allele-wise tests under an additive
model. Bold indicates 3 top SNP associations for imputed data (P<10-6) not observed in the
genotyped data. Bold plus grey shading indicates hits that coincide with top gene of functional
interest (BCL9) presented in main Table 2, as well as a hit near IGF2BP2 a previously observed
GWAS hit for T2D (see S4 Table).
(PDF)
S1 Text. Supplement on Conditional Analyses.
(PDF)
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